🇺🇸 FDA
Patent

US 7078552

Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs

granted A61KA61K47/55

Quick answer

US patent 7078552 (Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs) held by THE ARIZONA BOARD OF REGENTS expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE ARIZONA BOARD OF REGENTS
Grant date
Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K47/55